{"id":371,"date":"2014-05-06T13:16:01","date_gmt":"2014-05-06T11:16:01","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/"},"modified":"2026-10-06T06:29:26","modified_gmt":"2026-10-06T03:29:26","slug":"astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/","title":{"rendered":"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<div class=\"new_item_title\">Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &#8220;AstraZeneca&#8221; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.<\/div>\n<p>&#8220;Pfizer&#8221; paaugstin\u0101jis &#8220;AstraZeneca&#8221; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &#8220;AstraZeneca&#8221; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u, kas uz\u0146\u0113mumu nov\u0113rt\u0113 p\u0101r\u0101k zemu.<\/p>\n<p>&#8220;AstraZeneca&#8221; jau iepriek\u0161 noraid\u012bja s\u0101kotn\u0113jo &#8220;Pfizer&#8221; izteikto neofici\u0101lo p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kura v\u0113rt\u012bba veidoja aptuveni 100 miljardus dol\u0101ru, zi\u0146o LETA.<\/p>\n<p>www.farmacija-mic.lv<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &#8220;AstraZeneca&#8221; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA. &#8220;Pfizer&#8221; paaugstin\u0101jis &#8220;AstraZeneca&#8221; iepriek\u0161 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11882,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[9,70,76],"tags":[],"mic_flag":[],"class_list":["post-371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-arzemes","category-farmacijas-zinas","category-jaunakie-raksti"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &quot;AstraZeneca&quot; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &quot;Pfizer&quot; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.&quot;Pfizer&quot; paaugstin\u0101jis &quot;AstraZeneca&quot; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &quot;AstraZeneca&quot; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &quot;AstraZeneca&quot; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &quot;Pfizer&quot; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.&quot;Pfizer&quot; paaugstin\u0101jis &quot;AstraZeneca&quot; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &quot;AstraZeneca&quot; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t\t<meta property=\"og:image:height\" content=\"259\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-05-06T11:16:01+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:26+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &quot;AstraZeneca&quot; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &quot;Pfizer&quot; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.&quot;Pfizer&quot; paaugstin\u0101jis &quot;AstraZeneca&quot; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &quot;AstraZeneca&quot; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"name\":\"\\u0100rzem\\u0113s\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"position\":2,\"name\":\"\\u0100rzem\\u0113s\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#listItem\",\"name\":\"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#listItem\",\"position\":3,\"name\":\"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/arzemes\\\/#listItem\",\"name\":\"\\u0100rzem\\u0113s\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#newsarticle\",\"name\":\"\\u201cAstraZeneca\\u201d noraida \\u201cPfizer\\u201d izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/pills.jpg\",\"width\":620,\"height\":259},\"datePublished\":\"2014-05-06T13:16:01+03:00\",\"dateModified\":\"2026-10-06T06:29:26+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#webpage\"},\"articleSection\":\"\\u0100rzem\\u0113s, Farm\\u0101cija, Jaun\\u0101kie raksti\",\"dateline\":\"Published on May 6, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/\",\"name\":\"\\u201cAstraZeneca\\u201d noraida \\u201cPfizer\\u201d izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Zviedrijas un Lielbrit\\u0101nijas z\\u0101\\u013cu ra\\u017eot\\u0101js \\\"AstraZeneca\\\" piektdien, 2.maij\\u0101, noraid\\u012bjis ASV konkurenta \\\"Pfizer\\\" izteikto jaun\\u0101ko p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101jumu, kas b\\u016btu rad\\u012bjis pasaul\\u0113 liel\\u0101ko farm\\u0101cijas uz\\u0146\\u0113mumu, zi\\u0146o a\\u0123ent\\u016bra LETA.\\\"Pfizer\\\" paaugstin\\u0101jis \\\"AstraZeneca\\\" iepriek\\u0161 izteikt\\u0101 p\\u0101r\\u0146em\\u0161anas pied\\u0101v\\u0101juma v\\u0113rt\\u012bbu l\\u012bdz 106 miljardiem dol\\u0101ru (76 miljardiem eiro), ta\\u010du \\\"AstraZeneca\\\" valde piektdien pazi\\u0146ojusi, ka bez vilcin\\u0101\\u0161an\\u0101s \\u0161o pied\\u0101v\\u0101jumu noraida, raksturojot to k\\u0101 neatbilsto\\u0161u,\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/pills.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#mainImage\",\"width\":620,\"height\":259},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\\\/#mainImage\"},\"datePublished\":\"2014-05-06T13:16:01+03:00\",\"dateModified\":\"2026-10-06T06:29:26+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs","description":"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js \"AstraZeneca\" piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta \"Pfizer\" izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.\"Pfizer\" paaugstin\u0101jis \"AstraZeneca\" iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du \"AstraZeneca\" valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,","canonical_url":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","name":"\u0100rzem\u0113s"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","position":2,"name":"\u0100rzem\u0113s","item":"https:\/\/farmacija-mic.lv\/category\/arzemes\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#listItem","name":"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#listItem","position":3,"name":"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/arzemes\/#listItem","name":"\u0100rzem\u0113s"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#newsarticle","name":"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg","width":620,"height":259},"datePublished":"2014-05-06T13:16:01+03:00","dateModified":"2026-10-06T06:29:26+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#webpage"},"articleSection":"\u0100rzem\u0113s, Farm\u0101cija, Jaun\u0101kie raksti","dateline":"Published on May 6, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/","name":"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs","description":"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js \"AstraZeneca\" piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta \"Pfizer\" izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.\"Pfizer\" paaugstin\u0101jis \"AstraZeneca\" iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du \"AstraZeneca\" valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#mainImage","width":620,"height":259},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/#mainImage"},"datePublished":"2014-05-06T13:16:01+03:00","dateModified":"2026-10-06T06:29:26+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs","og:description":"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &quot;AstraZeneca&quot; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &quot;Pfizer&quot; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.&quot;Pfizer&quot; paaugstin\u0101jis &quot;AstraZeneca&quot; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &quot;AstraZeneca&quot; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,","og:url":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg","og:image:width":620,"og:image:height":259,"article:published_time":"2014-05-06T11:16:01+00:00","article:modified_time":"2026-10-06T03:29:26+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Zviedrijas un Lielbrit\u0101nijas z\u0101\u013cu ra\u017eot\u0101js &quot;AstraZeneca&quot; piektdien, 2.maij\u0101, noraid\u012bjis ASV konkurenta &quot;Pfizer&quot; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu, kas b\u016btu rad\u012bjis pasaul\u0113 liel\u0101ko farm\u0101cijas uz\u0146\u0113mumu, zi\u0146o a\u0123ent\u016bra LETA.&quot;Pfizer&quot; paaugstin\u0101jis &quot;AstraZeneca&quot; iepriek\u0161 izteikt\u0101 p\u0101r\u0146em\u0161anas pied\u0101v\u0101juma v\u0113rt\u012bbu l\u012bdz 106 miljardiem dol\u0101ru (76 miljardiem eiro), ta\u010du &quot;AstraZeneca&quot; valde piektdien pazi\u0146ojusi, ka bez vilcin\u0101\u0161an\u0101s \u0161o pied\u0101v\u0101jumu noraida, raksturojot to k\u0101 neatbilsto\u0161u,","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/pills.jpg"},"aioseo_meta_data":{"post_id":"371","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-23 01:09:56","updated":"2026-10-07 11:35:04"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/arzemes\/\" title=\"\u0100rzem\u0113s\">\u0100rzem\u0113s<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cAstraZeneca\u201d noraida \u201cPfizer\u201d izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"\u0100rzem\u0113s","link":"https:\/\/farmacija-mic.lv\/category\/arzemes\/"},{"label":"&#8220;AstraZeneca&#8221; noraida &#8220;Pfizer&#8221; izteikto jaun\u0101ko p\u0101r\u0146em\u0161anas pied\u0101v\u0101jumu","link":"https:\/\/farmacija-mic.lv\/en\/astrazeneca-noraida-pfizer-izteikto-jaunako-parnemsanas-piedavajumu\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=371"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/371\/revisions"}],"predecessor-version":[{"id":2102,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/371\/revisions\/2102"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/11882"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=371"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}